The insulinotropic effect of GIP is impaired in patients with chronic pancreatitis and secondary diabetes mellitus as compared to patients with chronic pancreatitis and normal glucose tolerance-Reference-Cited by-同舟云学术

The insulinotropic effect of GIP is impaired in patients with chronic pancreatitis and secondary diabetes mellitus as compared to patients with chronic pancreatitis and normal glucose tolerance

Published:2007-12 Issue:1-3 Volume:144 Page:123-130
ISSN:0167-0115
Container-title:Regulatory Peptides
language:en
Short-container-title:Regulatory Peptides

Author:

Knop Filip K.,Vilsbøll Tina,Højberg Patricia V.,Larsen Steen,Madsbad Sten,Holst Jens J.,Krarup Thure

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Clinical Biochemistry,Endocrinology,Physiology,Biochemistry

Reference33 articles.

1. Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses;Nauck;J Clin Endocrinol Metab,1986

2. On the physiology of GIP and GLP-1;Holst;Horm Metab Res,2004

3. Nutrient, neural and endocrine control of glucagon-like peptide secretion;Dube;Horm Metab Res,2004

4. Reduced incretin effect in type 2 (non-insulin-dependent) diabetes;Nauck;Diabetologia,1986

5. Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients;Vilsboll;Diabetologia,2002

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk Factors and Mechanisms for Diabetes in Pancreatitis;Gastroenterology Clinics of North America;2024-09

2. Safety of native glucose-dependent insulinotropic polypeptide in humans;Peptides;2024-07

3. Differential Diagnosis of Post Pancreatitis Diabetes Mellitus Based on Pancreatic and Gut Hormone Characteristics;The Journal of Clinical Endocrinology & Metabolism;2024-02-12

4. Treatment with the dual-incretin agonist DA-CH5 demonstrates potent therapeutic effect in a rat model of Wolfram Syndrome;Frontiers in Endocrinology;2023-10-13

5. Perspectives on weight control in diabetes – Tirzepatide;Diabetes Research and Clinical Practice;2023-08